Please login to the form below

Not currently logged in


This page shows the latest mRNA-4157 news and features for those working in and with pharma, biotech and healthcare.

Moderna posts encouraging early data for personalised cancer vaccine

Moderna posts encouraging early data for personalised cancer vaccine

The vaccine, mRNA-4157, is being evaluated in combination with Merck &Co’s PD-1 inhibitor Keytruda (pembrolizumab) in different cancer types. ... According to Moderna, the data showed that mRNA-4157 is well tolerated, with adverse events being

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...